This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Nao Kurokawa: Innovator in Adjuvant Composition
Introduction
Nao Kurokawa is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of adjuvant compositions. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving medical formulations.
Latest Patents
Kurokawa holds a patent for an "Adjuvant composition, adjuvant preparation containing same, and kit." This patent describes an adjuvant composition that includes lauryl alcohol and propylene glycol. The specific contents of lauryl alcohol and propylene glycol range from 0.5 to 25% by mass and 8.0 to 99.5% by mass, respectively, relative to the total mass of the adjuvant composition. The lauryl alcohol is dissolved, and the composition is intended for transdermal or transmucosal administration. This innovative formulation has the potential to enhance the efficacy of various therapeutic agents.
Career Highlights
Nao Kurokawa is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to contribute to advancements in pharmaceutical technology. His work is characterized by a commitment to developing effective and safe medical products that can improve patient outcomes.
Collaborations
Kurokawa collaborates with esteemed colleagues such as Seiji Tokumoto and Kazuya Machida. Their combined expertise fosters a productive environment for innovation and research within the pharmaceutical industry.
Conclusion
Nao Kurokawa's contributions to the field of adjuvant compositions exemplify his role as a leading inventor in pharmaceutical sciences. His innovative patent and collaborative efforts highlight the importance of research and development in creating effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile